DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
RNXT RenovoRx
- 1.040
- +0.010+0.97%
Close Feb 14 16:00 ET
- 1.060
- +0.020+1.92%
Post 20:01 ET
36.99MMarket Cap-1.79P/E (TTM)
1.090High1.010Low296.62KVolume1.010Open1.030Pre Close309.20KTurnover0.85%Turnover RatioLossP/E (Static)35.57MShares1.86052wk High5.23P/B36.51MFloat Cap0.77452wk Low--Dividend TTM35.11MShs Float16.740Historical High--Div YieldTTM7.77%Amplitude0.531Historical Low1.042Avg Price1Lot Size
About RenovoRx Company
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Mountain View, CA.
Company Profile
SymbolRNXT
Company NameRenovoRx
Listing DateAug 26, 2021
Issue Price9.00
Founded2012
CEOMr. Shaun R. Bagai
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address2570 West El Camino Real,Suite 320
CityMountain View
ProvinceCalifornia
CountryUnited States of America
Zip Code94040
Phone1-650-284-4433
Websitehttp://www.renovorx.com
Company Executives
- Name
- Position
- Salary
- Shaun R. Bagai
- Chief Executive Officer and Director
- 939.12K
- Dr. Ramtin Agah, M.D.
- Chief Medical Officer and Chairman of the Board
- 507.76K
- Leesa Gentry
- Chief Clinical Officer
- --
- Ronald B. Kocak
- Vice President, Controller and Principal Accounting Officer
- --
- Dr. Una S. Ryan,PhD
- Independent Director
- 82.00K
- Dr. Robert J. Spiegel, F.A.C.P.,M.D.
- Independent Director
- 173.72K
- Dr. Laurence J. Marton, M.D.
- Independent Director
- 77.00K
- Kirsten Angela Macfarlane
- Independent Director
- 82.00K